Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-22-023 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technolog...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 24, 2022 Category: Research Source Type: funding
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-22-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high-value informatics research resources to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Techno...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 24, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data.
Notice NOT-CA-22-056 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2022 Category: Research Source Type: funding
Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-23-009 from the NIH Guide for Grants and Contracts. oThis initiative will fund exploratory or pilot research projects to test interventions that address social connectedness and/or loneliness in order to prevent or treat SUDs or enhance recovery for individuals with SUDs. Interventions funded through this initiative should build on foundational, epidemiologic research on social connectedness and loneliness, and help contribute to a more unified theory about the role of loneliness and social connectedness in substance use and SUDs. Interventions could be delivered at the individual, dyadic, fam...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2022 Category: Research Source Type: funding
Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 - Clinical Trial Optional)
Funding Opportunity RFA-DA-23-010 from the NIH Guide for Grants and Contracts. This initiative will fund exploratory or pilot research projects to test interventions that address social connectedness and/or loneliness in order to prevent or treat SUDs or enhance recovery for individuals with SUDs. Interventions funded through this initiative should build on foundational, epidemiologic research on social connectedness and loneliness, and help contribute to a more unified theory about the role of loneliness and social connectedness in substance use and SUDs. Interventions could be delivered at the individual, dyadic, fami...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2022 Category: Research Source Type: funding
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-128 from the NIH Guide for Grants and Contracts. The National Eye Institute (NEI) supports large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies. At the time of submission, applications requesting support for these activities are expected to provide detailed information regarding the study rationale, design, analytic techniques, protocols and procedures, facilities and environment, organizational structure, and collaborative arrangements. This information is best conveyed in a well-documented Manual of Procedures (MOP), the development of...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 2, 2022 Category: Research Source Type: funding
Dear Colleague Letter: Incorporating Human Behavior in Epidemiological Models (IHBEM)
Available Formats: HTML: https://www.nsf.gov/pubs/2022/nsf22054/nsf22054.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2022/nsf22054/nsf22054.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf22054Public Comment: This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - March 2, 2022 Category: Science Source Type: funding
Notice of Special Interest (NOSI): Epidemiology of Drug Abuse
Notice NOT-DA-22-004 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 23, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
Notice NOT-CA-22-037 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 27, 2022 Category: Research Source Type: funding
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Funding Opportunity RFA-HL-23-010 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications to further develop enabling technologies and transformative platforms to catalyze next-generation predictive, diagnostic and therapeutic products to address heart, lung, blood, and sleep (HLBS)-related disorders and diseases. This FOA solicits R33 applications where major feasibility gaps for the enabling technology or transformative platform have already been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous v...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2022 Category: Research Source Type: funding
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-084 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote epidemiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 21, 2022 Category: Research Source Type: funding
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-083 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote epidemiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 21, 2022 Category: Research Source Type: funding
Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
Funding Opportunity RFA-DA-22-038 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to incre...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 10, 2022 Category: Research Source Type: funding
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
Funding Opportunity RFA-DA-22-037 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to incre...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 10, 2022 Category: Research Source Type: funding
Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional)
Funding Opportunity RFA-MH-22-171 from the NIH Guide for Grants and Contracts. Efforts are underway to develop a safe and effective vaccine to protect people from acquiring HIV ultimately reducing the number of new infections and ending the epidemic. However, the subject of vaccines remains contentious, and COVID-19 has heightened the conversation. There are multiple messages circulating both for and against vaccines and a growing number of skeptics appear to be making decisions about vaccines based on misinformation. This initiative will advance research on communication factors and strategies that will be crucial for ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 3, 2022 Category: Research Source Type: funding
